Tuesday, September 16, 2025
HomeIndustriesBiotechnology

Biotechnology

Arialys Therapeutics Appoints Peter Flynn, Ph.D., President and Chief Executive Officer

Arialys Therapeutics, a biotechnology company pioneering new precision medicines for autoimmune neuropsychiatry, announced the appointment of Peter Flynn, Ph.D., as President and Chief Executive...

Axogen, Inc Announces Full Launch of Avive+ Soft Tissue Matrix™

Axogen, Inc, a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, announces the launch of its newest product, Avive+...

Faro Health Inc. Appoints Vivian DeWoskin as Chief Strategy Officer

Faro Health Inc., the leading SaaS platform for data-driven clinical development, is pleased to announce the appointment of Vivian DeWoskin as Chief Strategy Officer. Vivian...

Aurion Biotech Receives Breakthrough Therapy Designation and Regenerative Medicine Advanced Therapy Designation for Its Drug Candidate AURN001

Aurion Biotech, whose mission is to restore vision to millions of patients with life-changing regenerative therapies, announced that the U.S. Food and Drug Administration...

Read Magazine’s Weekly Roundup: Discover the Most Recent News Actelis, GrayMatter, Target, Oliver Wyman and More !

Here is Read Magazine’s Weekly Roundup of the top news from global markets. In this fast-paced world, breaking down information helps readers grasp the...
0FansLike
0FollowersFollow
spot_img

Hot Topics